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INTRODUCTION:Oral carcinoma can cause signiﬁcant defects thatwould necessitate a challenging recons-
tructive surgery. These techniques include biological or synthetic dressings, grafts, regional ﬂaps, and
free-vascularized ﬂaps. Among these, the dural graft has demonstrated promising results in repairing the
skull-base defects. Our aim is to report a new, innovative technique for partial glossectomy and ﬂoor of
mouth defect repair using a biological dural graft dressing when primary repair was not feasible and the
patient did not consent to dermal graft or ﬂap interventions.
PRESENTATIONOFCASE:This article reports the outcomes fromanovel interventionof partial glossectomy
repairusingabiological duraldressingderived frombovine type-I collagen ina57-year-old femalepatient
with recurrent T1N1M0 squamous cell carcinoma of the left-sided tongue during the 12 month period of
follow-up.
DISCUSSION: The best option for large tongue defects is a free ﬂap,while for amoderate defect is a regional
oral ﬂap. The biological graft, as an acellular dermal graft has been well known to facilitate secondary
healing in the tongue as an alternative to the split-thickness skin graft. In the current study, the dural
dressing in tongue reconstruction was likewise shown to be an effective biological dressing; hence, the
collagen membrane is biologically acceptable to the oral mucosa and an excellent wound graft material.
However, it is absolutely contraindicated in bovine hypersensitive patients.
CONCLUSION: The biological dural graft dressing appears to be an effective method for tongue recon-
struction, as it promotes adequate wound healing and it preserves function.
© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
1. Introduction
Oral carcinoma can cause signiﬁcant mucosal and bony defects
that can necessitate a challenging reconstructive surgery. Oral and
pharyngeal cancer is the sixth-most commonly occurring cancer
internationally [1]. In the United States, cancers of the oral cav-
ity account for nearly 2.3% of cancers; the survival rate is 60–80%
for stages I and II, 40% for stage III, and 20% for stage IV [2]. The
major risk factors for the development of cancers of the oral cavity
are smoking and alcohol consumption, which when combined can
exert a synergistic effect [3].
Primary surgical treatment is an effective modality in the
treatmentof T1–T2oral tonguecarcinoma, anda lowrateof compli-
cations can normally be anticipated [4]. Selective neck dissection
Abbreviation: ADM, acellular dermal membrane graft; STSG, split thickness skin
graft.
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is usually required even for N0 neck, especially if microvascular
access will be required for ﬂap reconstruction [4].
Adjuvant treatment consists of postoperative radiotherapy
(interstitial or percutaneous), either alone or combined with
chemotherapy. Typical indications for adjuvant treatment include
the presence of positive surgical margins when further surgery is
not feasible, advanced neck disease, a tumor inﬁltration depth of
greater than 5mm, extracapsular tumor spread, and the inﬁltration
of lymph vessels or nerves in the histology [4].
A reconstruction technique can be used to ensure adequate
woundhealing, thepreservationof functions, and cosmetic appear-
ance. These techniques include free vascularized ﬂaps [5], local
region ﬂaps such as buccinator myomucosal ﬂaps and skin grafts
[6]. Furthermore, the biological graft has been well known to facil-
itate secondary healing in the tongue with the use of acellular
dermalmembranegraft (ADM)as alternative of split-thickness skin
graft (STSG) [7]. The current study reports a novel clinical experi-
ence in the ﬁeld of tongue reconstruction with the use of a different
type of dermal dressing which is the dural graft.
Dural grafts are well known from their use in sinus, otologic,
and skull-base surgeries. These grafts can be used to prevent cere-
brospinal leak or as a septal reinforcement graft in epistaxis cases
http://dx.doi.org/10.1016/j.ijscr.2015.04.029
2210-2612/© 2015 The Authors. Published by Elsevier Ltd. on behalf of Surgical Associates Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
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arising from hereditary hemorrhagic telangiectasia. Several dural
substitutes are currently commercially available [8]. Among these
dural substitutes, only semisynthetic collagen matrix grafts appear
promising; this is because they are thought to provide a matrix
for ingrowth of, and subsequent replacement by, endogenous con-
nective tissue, while continuously presenting a mechanical barrier
[9].
Our aim is to report, a new innovative technique for partial glos-
sectomy and ﬂoor of mouth defect repair using a biological dural
graft dressingwhen primary repairwas not feasible and the patient
did not consent to dermal graft, regional or free vascular ﬂap inter-
vention.
2. Presentation of case
2.1. History
A 57-year-old female patient complained of a tongue lesion on
the left lateral tongue lasting twomonths. The lesionﬁrst presented
as a white patch and progressively increased in size and was asso-
ciated with mild pain. The patient had no history of dysphagia or
hoarseness. The patient had a 30 pack year smoking history.
2.2. Examination
On examination, the patient had a left lateral tongue lesion. It
was approximately 1.4×2.7 cm in greatest dimension, and there
was no detectable mass in the nasopharynx or larynx. The vocal
cordsweremobile bilaterally. No palpable neckmasswas detected.
The patient underwent biopsy of the left tongue lesion, which
showed well-differentiated invasive squamous cell carcinoma.
A preoperative evaluation, a CT scan of the chest, neck, abdomen
and pelvis showed a left lateral anterior tongue lesion 2.5×1.5 cm
with multiple enlarged ipsilateral left neck lymph nodes (Level II,
1.5 cm and Level III, approximately 2 cm). MRI of the neck showed
the same ﬁndings as CT. The ﬁne needle aspiration of lymph nodes
showed equivocal results with no deﬁnitive diagnosis. The clinical
stage of the patient was T2N2bM0 squamous cell carcinoma of the
tongue.
2.3. First procedure
The patientwas admitted in January 2014 to undergo left partial
glossectomywith primary closure and left selective neck dissection
of levels I–IV.
2.3.1. Histopathology
Histopathological analysis revealed a well-differentiated inva-
sive squamous cell carcinoma of the tongue. The tumor was 1.6 cm
in size at its greatest diameter and was found to be in stage pT1.
The tumor thickness was 0.7 cm, a focus of perineural invasion was
present, no lymphovascular invasion was discovered, and all sur-
gical margins were free. One of the 14 lymph nodes was positive
formetastasis,whichmeasured1.3 cm.Deﬁnitivehistopathological
staging was T1N1M0.
The patient condition was discussed at the multidisciplinary
head and neck tumor board after the initial procedure and because
the permanent histopathology examinations revealed a perineu-
ral invasion with one ipislateral lymph node that is positive for
malignancy, which measured 1.3 cm, the decision was made to ini-
tiate conventional fractionated radiotherapy of both the primary
site of tongue and the neck with a total dose of 60Gy in 30 frac-
tions (2Gy per fraction in 6 weeks treating 5 days per week), to be
given 6 weeks after the ﬁrst operation. This administration sched-
ule was selected as the literature has reported that postoperative
Fig. 1. Tongue lesion before the revision partial glossectomy and dural graft dress-
ing.
Fig. 2. Dural graft after revision partial glossectomy with dural graft dressing.
radiotherapy should be planned to be commenced 3–8 weeks after
surgery [10].
2.3.2. Follow-up
The patient developed difﬁculty in swallowing and speech that
resolved after 10 days. After 6 weeks, the patient presented to the
clinic complaining of tenderness and swelling at the site of the
tongue excision. Examination revealed a nodular lesion that was
measured as 1.8 inwidth and3.4 cm in lengthwith redness and ten-
derness (Fig. 1). The patient was scheduled for excisional biopsy of
the nodule to exclude persistent tongue cancer cells, although the
margins were free in the histopathology of ﬁrst procedure. How-
ever, it exhibited neural invasion and positive lymph node, which
are considered to be an intermediate risk for regional metastasis
and poor prognosis [11].
2.4. Second procedure
On February 12, 2014, the patient underwent completion of the
previously performed partial glossectomy using a frozen section
that demonstrated scar and chronic stomatitis with a foreign body
reaction, but no malignancy.
Following the revised excision, the defect was extended to the
ﬂoor of mouth, 2.8×4.4 cm including the excision of the lesion
with 1 cm around its borders to ensure that the margins were free
of malignancy. An attempt at primary closure of the defect would
have required the tongue to be tethered to the ﬂoor of the mouth;
this could have increased the patient’s difﬁculty in speech, masti-
cation, and deglutition. Consequently, another treatment modality
was considered. The promising results of the use of dural grafts in
repairing defects at the skull base encouraged us to implement a
dural graft in this case as biological dressing. We used DuraGen
which contains Type I collagen that is derived from the bovine
Achilles tendon. Thedural dressingwas4.5×3 cmin size, and itwas
placed over the defect in the left tongue and the ﬂoor of mouth. The
dressing was sutured and stabilized by interrupted vertical mat-
tress sutures through the interdental papilla and ﬂoor of mouth
using 3.0 VICRYL non-absorbable suture (Fig. 2).
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Fig. 3. Dural graft 1 week after revision partial glossectomy with dural graft dress-
ing.
2.4.1. Follow-up
Following the procedure, the patient experiencedmild difﬁculty
in articulation and swallowing. One week after the procedure, the
patient was able to swallow normally, but had experienced mild
difﬁculty in the protrusion of the tongue (Fig. 3). After 3 weeks,
the dural graft was removed and the granulation tissue demon-
stratedanormalhealingprocess. At theendof3months, thepatient
returned to her normal articulation. At the end of the 12 month
follow-up period, the tongue wound had healed completely with
surface epithelisation across the entire wound, but associated with
the usual side effect of stomatitis as a result of treatment with
radiotherapy (Fig. 4).
3. Discussion
In most cases of oral tongue cancer, reconstruction is challeng-
ing. If primary closure is not possible, reconstruction is needed to
facilitate the healing process and to obtain satisfactory swallowing
and articulation functions [12,13]. These reconstruction methods
include free-ﬂap reconstruction in cases of large defects, while for
moderate to mild defects, regional oral ﬂap, free skin grafting, and
biomaterial grafting are indicated [5]. There are various new tech-
niques for reconstruction, including the use of biological dressing
of fresh amniotic membrane graft [14] and the use of a polyglycolic
acid sheet with a ﬁbrin-glue spray [15].
The biological dural collagen dressing was used in this case
because the tongue and ﬂoor of mouth defect was unable to be
closed without causing tongue tethering. Additionally, the patient
had not previously planned for and consented to a regional ﬂap
or autograft procedure. The dural dressing is not an alternative
to standard reconstruction methods of regional ﬂap, but it is
one type of biological dressing that facilitates mucosal healing
similar to that of the split-thickness skin graft [7]. The following
describes the advantages and disadvantages of different modal-
ities of reconstruction. Free ﬂaps are the best option for large
defects. However, the use of free ﬂaps is associated with donor
site morbidity, and requires complex surgery. We concluded that
the optimal treatment for this patient with a moderate tongue
defect, and a previous history of neck dissection is the buccinator
musculomucosal regional ﬂap. The advantages of the regional
oral ﬂap are that it replaces the tongue mucosa with the same
type of mucosa, avoiding donor site morbidity, and achieving
optimal functional and cosmetic results [6]. The split-thickness
graft is also an effective method for moderate defect which can be
harvested from any body surface such as the anterior upper thigh
by using a powered dermatome set at 0.015 inch. thickness, it
has the advantage of easy availability, simplicity of harvest, rapid
healing of the graft in moist oral cavity and avoiding the risk of
rejection. However, the split thickness result in keratinized graft
in otherwise mucosal–lined cavity [7].
The use of biological dressing has the advantages of avoidance of
the creation of a donor site with its associated pain and morbidity,
reducedautologous skingraft thickness, andability tobeperformed
without requiring special surgical skills. However, some of these
products have the disadvantage of cost and availability [16]. Chern
et al. conducted a literature review of various biologic dressing
used in acute surgical wounds. The study compared the utility, out-
comes, and adverse effects among the different types of biological
dressings that included the composite, dermal and epidermal grafts
[16]. They found that the majority of studies of biological grafts in
acute surgical wounds have been conducted on composite grafts
such as Apligraf which is formed of the epidermal part of human
neonatal foreskin keratinocytes and the dermal part of neonatal
foreskin ﬁbroblast with bovine type I collagen matrix, which seems
to demonstrate favorable results of avoiding the creating a donor
site, and ease of wound care. However, the major disadvantage of
Fig. 4. Tongue 12 months after the revision partial glossectomy and dural graft dressing.
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composite grafts is their short shelf life. The dermal grafts such as
Integra are associated with numerous commercial products. One
of them is DuraGen which has been used in the current study. This
graft is formed fromcross-linkedbovine collagen andglycosamino-
glycan, it coated on one side with a silicone membrane and it has
shownpromise in inhibitingwoundcontraction, scar formationand
keloids. It has a role in the repair of defects where soft tissue bulk
is needed for coverage, such as with large scalp defects after exci-
sion of cutaneous malignancy. However, it is associated with the
risk of seroma and infection. An epidermal graft is an autologous
pinch graft of epidermal keratinocytes that is used as a permanent
wound coverage of a large area from a small amount of skin har-
vested but it is requires 3weeks for graft cultivation [16]. The use of
other biological graft dressings such as fresh amniotic membrane
grafts, has the advantage of facilitating healing and being charac-
terised by lower immunologicity [14], but fresh grafts are difﬁcult
to obtain on demand, as they become necessary. Although there
are limited studies on the use of porcine xenograft, dermatologic
surgeons widely use this product, which has the signiﬁcant beneﬁt
of low cost and immediate availability [16].
The use of bovine dural graft is absolutely contraindicated in
patientswithaknownhistoryofhypersensitivity tobovine-derived
materials.However, thepossibility of allergic reaction toduraplasty
material derived from bovine tissues is extremely low in patients
without history of bovine allergy, as the dural substitutes are pre-
pared in such a manner that they contain only chemically acellular
collagen with no other animal protein [17]. However, the litera-
ture has documented only one case report of allergic reaction to
dural graft derived from bovine tissue. In this case, the patient had
a history of myelomeningocele and he developed an allergic reac-
tion after the procedure of cord untethering with Durepair [18].
Furthermore, bovine dural graft is relatively contraindicated in the
presence of surgical site infection, as two cases of wound infections
have been reported in two studies consisting of 32 and 22 patients
who underwent bovine pericardial duraplasty [19,20].
The criteria for the judgment of dural graft dressing usefulness
are based on the Bessho and Murakami scale, which includes ﬁve
categories; the hemostatic effect on the day after operation, the
pain relief after one week, the granulation tissue formation at the
third week, the surface epithelialization after one month of the
surgery and the allergenicity to the material. These criteria were
judged as good, fair or poor, which were assigned scores of 2, 1,
and 0, respectively. Finally, usefulness of the material was graded
as very useful (8–10 points), useful (5–7 points), or useless (0–4
points) [21]. In the current case the biological dural graft was found
to be very useful receiving a total grade of 9 out of 10. This rating
was earned as a result of the hemostasis on the day after operation
beinggood (2points), and thepain score after oneweekbeing fair (1
points). The formation of granulation tissue in the third week was
good on the entire wound (2 points). The surface epithelialization,
assessed at the end of one month, was good (2 points). Moreover,
the patient had not developed any reactivity or allergenicity to the
material (2 points).
Regarding the radiotherapy effect, Girod et al. reported that the
radiation therapy had an adverse effect on both types of graft-
ing (ADM and STSG), while the ADM group still demonstrated
some improvement over the STSG group [7]. In our case, the
patient developed usual acute side effects of radiotherapy, includ-
ing stomatitis and xerostomia, but this did not compromise the
achievement of completehealingduring theperiodof the12month
follow-up.
4. Conclusion
The use of a biological dural graft with partial glossectomy was
an effective method for facilitating secondary healing in mild to
moderate mucosal tongue defect, when primary repair was not
feasible and thepatienthadnot consented fordermal graft, regional
or freevascularﬂapprocedures.Moreover, thebiological dural graft
exhibited the advantages of easy availability, the ability to be per-
formed without requiring special skills, and effectiveness in the
prevention of postoperative scar formation and contraction of the
tongue.
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